48
Participants
Start Date
August 31, 2009
Primary Completion Date
December 31, 2009
Study Completion Date
December 31, 2009
PF-03049423
PF-03049423 in oral solution, 2.5 mg, given once daily for 14 days; healthy young adult volunteers
PF-03049423
PF-03049423 in oral solution, 7.5 mg, given once daily for 14 days; healthy young adult volunteers
PF-03049423
PF-03049423 in oral solution, 6 mg, given once daily for 7 days, then 12 mg given once daily for 7 days; healthy young adult volunteers
PF-03049423
PF-03049423 in oral solution, 3 mg, given once daily for 7 days, then 6 mg given once daily for 7 days; healthy elderly adult volunteers
PF-03049423
PF-03049423 in oral solution, 5 mg, given once daily for 7 days, then 10 mg given once daily for 7 days; healthy elderly adult volunteers
Placebo
Placebo in oral solution, given once daily for 14 days
Pfizer Investigational Site, Brussels
Lead Sponsor
Pfizer
INDUSTRY